129 related articles for article (PubMed ID: 9365453)
41. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma: long-term experiences.
Wagner D; Kern WV; Kern P
Clin Investig; 1994 Jun; 72(6):417-23. PubMed ID: 7950152
[TBL] [Abstract][Full Text] [Related]
42. Cardiotoxicity after liposomal anthracyclines.
Young AM; Dhillon T; Bower M
Lancet Oncol; 2004 Nov; 5(11):654. PubMed ID: 15522651
[No Abstract] [Full Text] [Related]
43. Successful treatment of an HIV-positive patient with unmasking Kaposi's sarcoma immune reconstitution inflammatory syndrome.
Speicher DJ; Sehu MM; Johnson NW; Shaw DR
J Clin Virol; 2013 Jul; 57(3):282-5. PubMed ID: 23578530
[TBL] [Abstract][Full Text] [Related]
44. [Successful treatment with liposomal doxorubicin and foscarnet in a patient with widespread Kaposi's sarcoma and human herpes virus 8-related, serious hemophagocytic syndrome, after renal transplantation].
Bossini N; Sandrini S; Setti G; Luppi M; Maiorca P; Maffei C; Cancarini G
G Ital Nefrol; 2005; 22(3):281-6. PubMed ID: 16001371
[TBL] [Abstract][Full Text] [Related]
45. Complete response of an HIV negative gastric Kaposi's sarcoma (KS) patient with peritoneal carcinomatosis by liposomal daunorubicin treatment.
Fléchon A; Lombard-Bohas C; Boulez J; Blay JY; Scoazec JY
Ann Oncol; 2001 Feb; 12(2):275-6. PubMed ID: 11300338
[TBL] [Abstract][Full Text] [Related]
46. Liposomal encapsulated anthracyclines: new therapeutic horizons.
Muggia FM
Curr Oncol Rep; 2001 Mar; 3(2):156-62. PubMed ID: 11177748
[TBL] [Abstract][Full Text] [Related]
47. KS treatment inches forward.
Vazquez E
Posit Aware; 1996; 7(5):9. PubMed ID: 11363790
[TBL] [Abstract][Full Text] [Related]
48. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
Cheung TW; Remick SC; Azarnia N; Proper JA; Barrueco JR; Dezube BJ
Clin Cancer Res; 1999 Nov; 5(11):3432-7. PubMed ID: 10589755
[TBL] [Abstract][Full Text] [Related]
49. Psoriasiform pustular eruptions from pegylated-liposomal doxorubicin in AIDS-related Kaposi's sarcoma.
Kreuter A; Gambichler T; Schlottmann R; Altmeyer P; Brockmeyer N
Acta Derm Venereol; 2001; 81(3):224. PubMed ID: 11558892
[No Abstract] [Full Text] [Related]
50. KS update.
Notes Undergr; 1995; (no 29):4. PubMed ID: 11362282
[TBL] [Abstract][Full Text] [Related]
51. Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients.
La-Beck NM; Zamboni BA; Gabizon A; Schmeeda H; Amantea M; Gehrig PA; Zamboni WC
Cancer Chemother Pharmacol; 2012 Jan; 69(1):43-50. PubMed ID: 21590446
[TBL] [Abstract][Full Text] [Related]
52. Liposomal chemotherapies.
Smart T
GMHC Treat Issues; 1995; 9(7/8):13. PubMed ID: 11362653
[TBL] [Abstract][Full Text] [Related]
53. Classic Mediterranean Kaposi's sarcoma regression with sirolimus treatment.
Guenova E; Metzler G; Hoetzenecker W; Berneburg M; Rocken M
Arch Dermatol; 2008 May; 144(5):692-3. PubMed ID: 18490609
[No Abstract] [Full Text] [Related]
54. Penile ulceration during pegylated doxorubicin chemotherapy of classical Kaposi's sarcoma.
Cannavò SP; Borgia F; Scimone A; Guarneri B
Acta Derm Venereol; 2009; 89(2):216-7. PubMed ID: 19326025
[No Abstract] [Full Text] [Related]
55. Liposomal daunorubicin as treatment for Kaposi's sarcoma.
Petre CE; Dittmer DP
Int J Nanomedicine; 2007; 2(3):277-88. PubMed ID: 18019828
[TBL] [Abstract][Full Text] [Related]
56. Triple secondary neoplasms: penis, lip and oral cavity in an AIDS patient treated with pegylated liposomal doxorubicin for cutaneous Kaposi's sarcoma.
Volkow P; Lizano M; Carrillo-García A; Pérez-Montiel D; Garciadiego P
AIDS; 2014 Sep; 28(15):2327-9. PubMed ID: 25313589
[No Abstract] [Full Text] [Related]
57. AIDS-related Kaposi's sarcoma with chylothorax and pericardial involvement satisfactorily treated with liposomal doxorubicin.
Maradona JA; Carton JA; Asensi V; Rodríguez-Guardado A
AIDS; 2002 Mar; 16(5):806. PubMed ID: 11964546
[No Abstract] [Full Text] [Related]
58. HIV-associated Kaposi's sarcoma.
Seybold U; Mayr D; Degenhart C; Bogner JR
Infection; 2008 Feb; 36(1):96-7. PubMed ID: 18231715
[No Abstract] [Full Text] [Related]
59. Doxorubicin liposome formulation gains marketing approval.
Am J Health Syst Pharm; 1996 Jan; 53(2):116, 119. PubMed ID: 8653476
[No Abstract] [Full Text] [Related]
60. Endemic African Kaposi's sarcoma: clinical and therapeutic implications. 10-year experience in the Johannesburg Hospital (1980-1990).
Stein ME; Spencer D; Ruff P; Lakier R; MacPhail P; Bezwoda WR
Oncology; 1994; 51(1):63-9. PubMed ID: 8265105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
